Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion type Assertion NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_head.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion evidence source_evidence_literature NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion SIO_000772 21844874 NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion wasDerivedFrom befree-20140225 NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion wasGeneratedBy ECO_0000203 NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.